av/avalo-therapeutics--big.svg

COM:AVALOTX

Avalo Therapeutics, Inc.

  • Stock

USD

Last Close

9.65

22/11 21:00

Market Cap

12.97M

Beta: -

Volume Today

80.44K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-13.05M
-
-16.06M
23.08%
-10.49M
34.66%
-16.47M
57.02%
11.87M
172.06%
-40.05M
437.43%
-16.07M
59.87%
-63.50M
295.08%
-84.38M
32.88%
-41.66M
50.63%
-31.54M
24.28%
depreciation and amortization
20.03K
-
28.94K
44.48%
23.51K
18.78%
26.86K
14.24%
425.48K
1,484.29%
4.55M
970.56%
3.88M
14.74%
1.84M
52.54%
1.66M
10.10%
166K
89.98%
158K
4.82%
deferred income tax
-1.18M
-
-1.31M
10.88%
-72.63K
94.47%
-832.63K
1,046.48%
-16.75K
97.99%
16.74K
199.99%
195.59K
1,068.16%
22K
88.75%
28K
27.27%
14K
50%
stock based compensation
748.65K
-
1.09M
45.14%
394.75K
63.67%
1.69M
329.36%
1.16M
31.72%
2.43M
110.07%
2.53M
4.16%
6.79M
167.97%
8.17M
20.43%
7.55M
7.56%
3.48M
53.97%
change in working capital
644.26K
-
-383.29K
159.49%
927.77K
342.05%
87.07K
90.61%
-466.75K
636.05%
8.73M
1,971.04%
-2.03M
123.21%
-4.44M
118.93%
2.84M
163.99%
4.77M
68.02%
-2.42M
150.65%
accounts receivables
-247.19K
-
-222.53K
9.98%
1.66M
845.22%
-678.10K
140.89%
1.12M
264.72%
1.06M
5.10%
inventory
-202.62K
-
-311.20K
53.59%
532.95K
271.26%
18.20K
96.59%
-35K
292.33%
18K
151.43%
20K
11.11%
accounts payables
818.39K
-
-708.37K
186.56%
-268.71K
62.07%
332.10K
223.59%
96.06K
71.07%
82.45K
14.17%
1.02M
1,136.32%
98.52K
90.34%
796K
707.96%
-487K
161.18%
-2.44M
400.21%
other working capital
-174.13K
-
325.07K
286.69%
1.20M
268.06%
-245.03K
120.48%
-113.00K
53.88%
9.18M
8,227.84%
-5.24M
157.02%
-3.88M
26.00%
961K
124.80%
4.18M
334.86%
2.42M
42.19%
other non cash items
146.93K
-
989.26K
573.30%
293.75K
70.31%
162.27K
44.76%
366.23K
125.69%
21.22M
5,694.74%
-7.47M
135.19%
18.57M
348.70%
794K
95.72%
2.39M
200.88%
-369K
115.45%
net cash provided by operating activities
-11.49M
-
-15.52M
35.12%
-10.16M
34.51%
-14.57M
43.39%
12.52M
185.91%
-3.13M
124.99%
-19.13M
511.69%
-40.54M
111.87%
-70.89M
74.87%
-26.75M
62.27%
-30.68M
14.69%
investments in property plant and equipment
-29.27K
-
-19.50K
33.37%
-19.98K
2.47%
-34.88K
74.55%
-23.32K
33.13%
-564.41K
2,319.79%
-262.01K
53.58%
-62.66K
76.09%
-113K
80.34%
-95K
15.93%
acquisitions net
-18.89M
-
1.43M
107.57%
3.96M
176.84%
11.19M
182.81%
purchases of investments
-11.19T
-
sales maturities of investments
12.84T
-
other investing activites
-4.14M
-
-1.64T
39,663,102.48%
-133K
-
net cash used for investing activites
-29.27K
-
-19.50K
33.37%
-19.98K
2.47%
-34.88K
74.55%
-18.91M
54,116.26%
865.46K
104.58%
-443.00K
151.19%
11.13M
2,612.91%
-113K
101.02%
-95K
15.93%
-133K
40%
debt repayment
-1.81M
-
-3.31M
82.93%
-2.37M
28.37%
-256.14K
-
-32.90M
-
-14.81M
55.00%
common stock issued
23.69M
-
2.00M
91.54%
1.69M
15.46%
3.86M
127.76%
12.68M
228.86%
44.45M
250.44%
71.93M
61.81%
34K
99.95%
32.47M
95,400%
common stock repurchased
-1.37K
-
-33.96K
-
-93.87K
176.42%
366K
489.91%
73K
80.05%
67K
8.22%
dividends paid
-1.37K
-
-1.08M
-
-32.90M
-
-14.81M
55.00%
other financing activites
5.42M
-
23.86M
340.50%
-2.27M
109.51%
-114.94K
94.93%
4.42M
3,943.24%
6.55M
48.20%
1.25M
80.97%
426.27K
65.79%
100.27M
23,422.11%
14.81M
85.23%
-7.50M
150.62%
net cash used provided by financing activities
5.42M
-
23.86M
340.50%
19.60M
17.84%
-1.43M
107.27%
3.74M
362.07%
10.40M
178.40%
12.56M
20.72%
44.78M
256.58%
106.76M
138.39%
-14.70M
113.77%
25.04M
270.37%
effect of forex changes on cash
net change in cash
-6.10M
-
8.32M
236.45%
9.42M
13.20%
-16.03M
270.22%
-2.66M
83.44%
8.14M
406.55%
-7.02M
186.20%
15.38M
319.11%
35.76M
132.53%
-41.55M
216.19%
-5.77M
86.11%
cash at beginning of period
9.52M
-
3.42M
64.06%
11.74M
243.20%
21.16M
80.22%
5.13M
75.77%
2.61M
49.19%
10.75M
312.46%
3.73M
65.30%
19.11M
412.37%
54.86M
187.15%
13.32M
75.72%
cash at end of period
3.42M
-
11.74M
243.20%
21.16M
80.22%
5.13M
75.77%
2.47M
51.79%
10.75M
334.71%
3.73M
65.30%
19.11M
412.37%
54.86M
187.15%
13.32M
75.72%
7.55M
43.33%
operating cash flow
-11.49M
-
-15.52M
35.12%
-10.16M
34.51%
-14.57M
43.39%
12.52M
185.91%
-3.13M
124.99%
-19.13M
511.69%
-40.54M
111.87%
-70.89M
74.87%
-26.75M
62.27%
-30.68M
14.69%
capital expenditure
-29.27K
-
-19.50K
33.37%
-19.98K
2.47%
-34.88K
74.55%
-23.32K
33.13%
-564.41K
2,319.79%
-262.01K
53.58%
-62.66K
76.09%
-113K
80.34%
-95K
15.93%
free cash flow
-11.51M
-
-15.54M
34.94%
-10.18M
34.46%
-14.61M
43.45%
12.50M
185.54%
-3.69M
129.55%
-19.40M
425.29%
-40.60M
109.33%
-71.00M
74.88%
-26.85M
62.19%
-30.68M
14.28%

All numbers in USD (except ratios and percentages)